Understanding Europe’s New Clinical Trial Regulations

Learn more about the purpose of EU-CTR and uncover best practices for adapting to its requirements, with insights from the experts at Certara. You will gain a deeper understanding of these regulations and the requirements of using its CTIS to submit, assess, authorize, supervise, and report on clinical trials in the EU.

Read now to:

Understand the goals of EU-CTS and timeline for transitioning to CTIS use
Explore best practices for adapting to a role-based system
Explore clinical trial anonymization and redaction methods
Improve patient engagement and stay in EMA compliance by utilizing plain language summaries (PLS)
Understand critical importance of proactively and accurately planning timelines under EU-CTR

Download the Whitepaper

Your company email address

Please select your industry: (max 1)

Opt In?

Berne Media may store and process my information. For details, see the Privacy Notice.
Citeline (previously Pharma Intelligence UK) may contact me with updates, relevant promotions and information about products. My Information will be used in accordance with the Citeline Privacy Policy, and you withdraw your permission to receive any of our communications at any time.
By clicking submit, you consent to allow Certara to store and process the information submitted to provide you the content requested. They are subject to Certara's Terms and Conditions.

Understanding Europe’s New Clinical Trial Regulations

Download the Whitepaper

Opt In?

Explore similar content

Safety & Regulatory Compliance Predictions For 2025

Maximizing value across drug development: Embracing a new CDMO and CRO partnership approach

Getting The Most Out Of Your Lab Space